'A drug that provides near-perfect protection against H.I.V. with shots just twice a year will be made available at $40 per patient annually in low- and middle-income countries, offering new hope for ending the H.I.V. epidemic.'
https://www.nytimes.com/2025/09/24/health/hiv-treatment-shots-lenacapavir.html
